{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:10:41Z","timestamp":1780362641782,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11739-021-02787-9","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T14:14:30Z","timestamp":1623507270000},"page":"2309-2311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report"],"prefix":"10.1007","volume":"16","author":[{"given":"Luigi Francesco","family":"Iannone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangelo","family":"Geppetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0326-4485","authenticated-orcid":false,"given":"Francesco","family":"De Cesaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"issue":"1","key":"2787_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1152\/japplphysiol.00094.2009","volume":"107","author":"M Lange","year":"2009","unstructured":"Lange M, Enkhbaatar P, Traber DL et al (2009) Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury. J Appl Physiol (1985). 107(1):176\u201384. https:\/\/doi.org\/10.1152\/japplphysiol.00094.2009","journal-title":"J Appl Physiol (1985)."},{"issue":"8","key":"2787_CR2","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/01.CIR.101.8.923","volume":"101","author":"HC Champion","year":"2000","unstructured":"Champion HC, Bivalacqua TJ, Toyoda K et al (2000) In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation 101(8):923\u2013930. https:\/\/doi.org\/10.1161\/01.CIR.101.8.923","journal-title":"Circulation"},{"issue":"1","key":"2787_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molmed.2020.10.005","volume":"27","author":"T Skaria","year":"2021","unstructured":"Skaria T, Walchli T, Vogel J (2021) CGRP receptor antagonism in COVID-19: potential cardiopulmonary adverse effects. Trends Mol Med 27(1):7\u201310. https:\/\/doi.org\/10.1016\/j.molmed.2020.10.005","journal-title":"Trends Mol Med"},{"issue":"1","key":"2787_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s10194-018-0955-y","volume":"20","author":"S Sacco","year":"2019","unstructured":"Sacco S, Bendtsen L, Ashina M et al (2019) European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain 20(1):6. https:\/\/doi.org\/10.1186\/s10194-018-0955-y","journal-title":"J Headache Pain"},{"issue":"7","key":"2787_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/head.13853","volume":"60","author":"CE Robertson","year":"2020","unstructured":"Robertson CE (2020) Could CGRP antagonists be helpful in the fight against COVID-19? Headache 60(7):1450\u20131452. https:\/\/doi.org\/10.1111\/head.13853","journal-title":"Headache"},{"key":"2787_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s42399-020-00300-5","volume":"2","author":"N Joshi","year":"2020","unstructured":"Joshi N, McAree M, Klimowich K et al (2020) Oral candidiasis in a migraine patient taking erenumab and galcanezumab: a case report. SN Comprehens Clin Med 2:658\u2013661. https:\/\/doi.org\/10.1007\/s42399-020-00300-5","journal-title":"SN Comprehens Clin Med"},{"key":"2787_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1358\/dof.2021.46.4.3238324","volume":"46","author":"F Cipolla","year":"2021","unstructured":"Cipolla F, Capi M, Lionetto L et al (2021) Zavegepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, treatment of migraine. Drugs Fut. 46:281. https:\/\/doi.org\/10.1358\/dof.2021.46.4.3238324","journal-title":"Drugs Fut."},{"key":"2787_CR8","unstructured":"Safety and efficacy trial of zavegepant intranasal for hospitalized patients with COVID-19 requiring supplemental oxygen - full text view - ClinicalTrials.gov. 2021."},{"issue":"1","key":"2787_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10194-020-01211-5","volume":"22","author":"JM Cohen","year":"2021","unstructured":"Cohen JM, Ning X, Kessler Y, Rasamoelisolo M, Campos VR, Seminerio MJ et al (2021) Immunogenicity of biologic therapies for migraine: a review of current evidence. J Headache Pain 22(1):3. https:\/\/doi.org\/10.1186\/s10194-020-01211-5","journal-title":"J Headache Pain"},{"issue":"1","key":"2787_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/cimm.1995.1182","volume":"165","author":"H Sakuta","year":"1995","unstructured":"Sakuta H, Inaba K, Muramatsu S (1995) Calcitonin gene-related peptide enhances cytokine-induced IL-6 production by fibroblasts. Cell Immunol 165(1):20\u201325. https:\/\/doi.org\/10.1006\/cimm.1995.1182","journal-title":"Cell Immunol"},{"issue":"3","key":"2787_CR11","doi-asserted-by":"publisher","first-page":"bvaa199","DOI":"10.1210\/jendso\/bvaa199","volume":"5","author":"L Ochoa-Callejero","year":"2021","unstructured":"Ochoa-Callejero L, Garcia-Sanmartin J, Villoslada-Blanco P et al (2021) Circulating levels of calcitonin gene-related peptide are lower in COVID-19 patients. J Endocr Soc. 5(3):bvaa199. https:\/\/doi.org\/10.1210\/jendso\/bvaa199","journal-title":"J Endocr Soc."},{"key":"2787_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00369-y","author":"KN Arca","year":"2020","unstructured":"Arca KN, Starling AJ (2020) Treatment-refractory headache in the setting of COVID-19 pneumonia: migraine or meningoencephalitis? Case Report. SN Compr Clin Med. https:\/\/doi.org\/10.1007\/s42399-020-00369-y","journal-title":"SN Compr Clin Med."},{"issue":"10","key":"2787_CR13","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1111\/head.13980","volume":"60","author":"AS Tolebeyan","year":"2020","unstructured":"Tolebeyan AS, Zhang N, Cooper V et al (2020) Headache in patients with severe acute respiratory syndrome coronavirus 2 infection: a narrative review. Headache 60(10):2131\u20132138. https:\/\/doi.org\/10.1111\/head.13980","journal-title":"Headache"},{"key":"2787_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-021-00964-7","author":"P Martelletti","year":"2021","unstructured":"Martelletti P, Bentivegna E, Spuntarelli V et al (2021) Long-COVID Headache. SN Compr Clin Med. https:\/\/doi.org\/10.1007\/s42399-021-00964-7","journal-title":"SN Compr Clin Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-021-02787-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-021-02787-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-021-02787-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T07:21:07Z","timestamp":1635837667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-021-02787-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,12]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2787"],"URL":"https:\/\/doi.org\/10.1007\/s11739-021-02787-9","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,12]]},"assertion":[{"value":"19 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.G: received personal fees from Allergan, Eli Lilly, Novartis, Amgen, TEVA; Grants from Amgen, TEVA, Eli Lilly, Allergan, Chiesi; Scientific Advisory Board, Endosome Therapeutics; Founding scientist of FloNext srl, Spinoff of the University of Florence. F.D.C received personal fees from TEVA, Eli Lilly, Novartis. Other authors have no conflicting interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from the patient to utilize her medical records for the purpose of this report. All information has been appropriately anonymized.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}